Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment

• C. Hyde,
• B. Wake,
• S. Bryan,
• P. Barton,
• A. Fry-Smith,
• C. Davenport,
• F. Song

Affiliations

C. Hyde

Department of Public Health and Epidemiology, University of Birmingham, UK

B. Wake

Department of Public Health and Epidemiology, University of Birmingham, UK

S. Bryan

The Health Economics Facility, Health Services Management Centre, University of Birmingham, UK

P. Barton

The Health Economics Facility, Health Services Management Centre, University of Birmingham, UK

A. Fry-Smith

Department of Public Health and Epidemiology, University of Birmingham, UK

C. Davenport

Department of Public Health and Epidemiology, University of Birmingham, UK

F. Song

Department of Public Health and Epidemiology, University of Birmingham, UK